Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris

This publication has 16 references indexed in Scilit:

• Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay
  Journal of Pharmaceutical and Biomedical Analysis, 1991
• Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
  New England Journal of Medicine, 1991
• Rate-Dependent Class III Antiarrhythmic Action, Negative Chronotropy, and Positive Inotropy of a Novel Ik Blocking Drug, UK-68,798
  Journal of Cardiovascular Pharmacology, 1990
• Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.
  Circulation, 1990
• Class III Antiarrhythmic Action Linked with Positive Inotropy: Acute Electrophysiological and Inotropic Effects of Amiodaronein Vitro
  Basic & Clinical Pharmacology & Toxicology, 1990
• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989
• Class III Antiarrhythrnic Action Linked with Positive Inotropy: Effects of the d‐ and 1‐Isomer of Sotalol on Isolated Rat Atria at Threshold and Suprathreshold Stimulation
  Basic & Clinical Pharmacology & Toxicology, 1988
• A reference data base for multilead electrocardiographic computer measurement programs
  Journal of the American College of Cardiology, 1987
• Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone
  American Heart Journal, 1987
• Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
  Circulation, 1985